Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases
Clinical Trials: Asthma
A listing of clinical trials currently looking for volunteers to enroll in Asthma studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Updated
A Non-drug Study Profiling Asthma
Birmingham : Teva Investigational Site 10165 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Birmingham : University of Alabama at Birmingham Lung Health Center
Bronchial Thermoplasty in Severe Persistent Asthma
Birmingham : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Mobile : Pulmonary Associates of Mobile, P.C. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Arizona
Phoenix : Phoenix Children's Hospital
A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children
Phoenix : Call for Information (Investigational Site 1248)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Scottsdale : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Scottsdale : Call for Information (Investigational Site 1047)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Scottsdale : Teva Investigational Site 10104 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
Scottsdale : Allergy & Immunology Associates Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tucson : University of Arizona
Diagnosis of Exercise-Induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes
Tucson : University of Arizona, Arizona Respiratory Center
Long-acting Beta Agonist Step Down Study
Tucson : Desert Sun Clinical Research, LLC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Arkansas
Little Rock : Call for Information (Investigational Site 1200)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Little Rock : Little Rock Allergy & Asthma Clin Research Center Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
California
Huntington Park : Rx for Life, Inc.
Are you African-American? Do you have Asthma?
Los Angeles : California Allergy and Asthma Medical Group, Inc.
Do you have asthma?
Rolling Hills Estates : Peninsula Research Associates, Inc.
Do you have asthma?
Rolling Hills Estates : Peninsula Research Associates, Inc.
Do you or your child suffer from asthma?
View More »
Anaheim : Convergys Clinical Research, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Anaheim : Investigational Site Number 840047 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Anaheim : Anaheim Clinical Trials Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Bakersfield : Teva Investigational Site 10173 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bell : Call for Information (Investigational Site 1255)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Buena Park : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Costa Mesa : Teva Investigational Site 10163 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Costa Mesa : Amphastar Site 5
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Costa Mesa : West Coast Clinical Trials
Safety Study in Adolescent and Adult Patients With Asthma
Cypress : West Coast Clinical Trials, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Encinitas : Call for Information (Investigational Site 1087)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Encinitas : Teva Investigational Site 10156 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Encinitas : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Folsom : Site 1
WheezoMeter® Correlation Study
Fountain Valley : Call for Information (Investigational Site 1110)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Fountain Valley : Allianz Medical and Research Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Fountain Valley : Investigational Site Number 840043 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Fresno : Call for Information (Investigational Site 1098)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Fresno : Research Center of Fresno, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Fresno : Research Center of Fresno
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Fullerton : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Granada Hills : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Granada Hills : Teva Investigational Site 10151 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Huntington Beach : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Huntington Beach : Allergy & Asthma Specialists Medical Group
A Study of ARRY-502 in Patients With Persistent Asthma
Huntington Beach : Teva Investigational Site 10157 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Huntington Beach : Teva Investigational Site 10176 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Huntington Beach : Pediatric Care Medical Group Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Long Beach : Allergy & Asthma Care Center of Southern California
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Long Beach : Teva Investigational Site 10147 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Long Beach : West Coast Clinical Trials Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Long Beach : Investigational Site Number 840046 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Long Beach : Health Care Partners Medical Group
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Long Beach : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Los Angelas : Call for Information (Investigational Site 1057)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Los Angeles : GSK Investigational Site
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Los Angeles : Allergy Medical Clinic, Research Division
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Los Angeles : Los Angeles Clinical Site 110
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
Los Angeles : Call for Information (Investigational Site 1116)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Los Angeles : Allergy Medical Clinic - Research Division
A Study of ARRY-502 in Patients With Persistent Asthma
Los Angeles : California Allergy & Asthma Med. Group
A Study of ARRY-502 in Patients With Persistent Asthma
Los Angeles : California Allergy and Asthma Medical Group, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Los Angeles : California Allergy and Asthma Medical Group, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Los Angeles : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Los Angeles : Investigational Site Number 840032 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Los Angeles : Investigational Site Number 840036 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Los Angeles : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Los Angeles : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Los Angeles : Southern California Institute for Respiratory Diseases, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Mission Viejo : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Mission Viejo : Call for Information (Investigational Site 1045)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Mission Viejo : Southern California Research
A Study of ARRY-502 in Patients With Persistent Asthma
Mission Viejo : Investigational Site Number 840005 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Newport Beach : Teva Investigational Site 10136 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Newport Beach : Southern California Clinical Trials Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Orange : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Orange : Clinical Trials of Orange County, Inc.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Orange : Call for Information (Investigational Site 1131)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Orange : Call for Information (Investigational Site 1251)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Orange : Teva Investigational Site 10140 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Orange : Choc Pediatric Subspeciality Faculty Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Orange : Investigational Site Number 840007 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Orange : Investigational Site Number 840033 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Orange : Amphastar Site 8
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Orange : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Orange : CHOC PSF, AMD, Division of Allergy, Asthma and Immunology
Safety Study in Adolescent and Adult Patients With Asthma
Palmdal : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Rancho Mirage : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Rancho Mirage : Advances In Medicine Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Redwood : Allergy and Asthma Consultants
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Redwood City : Teva Investigational Site 10185 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Riverside : Teva Investigational Site 10143 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Riverside : Investigational Site Number 840048 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Riverside : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Riverside : Integrated Research Group Inc. Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Rolling Hills Estates : Peninsula Research Associates
A Study of ARRY-502 in Patients With Persistent Asthma
Rolling Hills Estates : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Rolling Hills Estates : Investigational Site Number 840035 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Sacramento : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Sacramento : Quality Control Research, Inc. Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
San Diego : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
San Diego : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
San Diego : San Diego Clinical Site 140
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
San Diego : Allergy Associates Medical Group
A Study of ARRY-502 in Patients With Persistent Asthma
San Diego : Teva Investigational Site 10130 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Diego : Teva Investigational Site 10182 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Diego : Allergy & Asthma Medical Group & Research Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Diego : Allergy and Asthma
Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device
San Diego : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Francisco : University of California San Francisco
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
San Francisco : Investigational Site Number 840041 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
San Francisco : Ovation Research Group
Impact of Asthma Treatments on Daily Activities
San Jose : Teva Investigational Site 10179 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Jose : Amphastar Site 1
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
San Jose : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Jose : Investigational Site Number 840039 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
San Jose : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Jose : Allergy & Asthma Associates of Santa Clara Valley Research Center
Safety Study in Adolescent and Adult Patients With Asthma
San Mateo : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Santa Rosa : Investigational Site Number 840024 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
South San Francisco : Genentech Trial Information Support Line
An Observational Study of the Use and Safety of Xolair During Pregnancy
Stockton : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Stockton : Teva Investigational Site 10106 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Stockton : Investigational Site Number 840002 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Stockton : Amphastar Site 4
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Stockton : Bensch Research Associates
Safety Study in Adolescent and Adult Patients With Asthma
Torrance : Call for Information (Investigational Site 1245)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Vista : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Walnut Creek : Call for Information (Investigational Site 1247)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Walnut Creek : Teva Investigational Site 10129 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Walnut Creek : Allergy & Asthma Clinical Research, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Walnut Creek : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Westlake Village : Call for Information (Investigational Site 1250)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Wildomar : Call for Information (Investigational Site 1203)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Colorado
Centennial : 1st International Clinical Research Center
Is your asthma uncontrolled?
Wheat Ridge : Western States Clinical Research, Inc.
Will you help us evaluate an investigational study medication for the treatment of moderate to severe Asthma?
View More »
Centennial : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Centennial : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Centennial : IMMUNOe International Research Centers
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Centennial : Teva Investigational Site 10145 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Centennial : Colorado Allergy & Asthma Centers, PC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Colorado Springs : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Colorado Springs : Call for Information (Investigational Site 1150)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Colorado Springs : Asthma & Allergy Associates PC
A Study of ARRY-502 in Patients With Persistent Asthma
Colorado Springs : Teva Investigational Site 10172 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Colorado Springs : Asthma And Allergy Associates, P.C. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Storms Clinical Research Institute Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Asthma & Allergy Associates, P.C. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Vectura Clinical Trial Site 10001
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Colorado Springs : Investigational Site Number 840031 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Denver : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Denver : Denver Clinical Site 160
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
Denver : Teva Investigational Site 10154 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Denver : National Jewish Health Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Denver : National Jewish Medical and Research Center
Cell Biology of Steroid Resistant Asthma
Denver : Investigational Site Number 840011 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Denver : Investigational Site Number 840017 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Denver : National Jewish Health
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Denver : National Jewish Health
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
Denver : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Denver : Colorado Allergy and Asthma Centers, P.C.
Safety Study in Adolescent and Adult Patients With Asthma
Denver : Colorado Allergy and Asthma Centers, PC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Engelwood : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Lakewood : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Thornton : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Wheat Ridge : Call for Information (Investigational Site 1008)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Wheat Ridge : Teva Investigational Site 10128 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Wheat Ridge : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Wheat Ridge : Rocky Mountain Center for Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
Wheat Ridge : Western States Clinical Research Inc. Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Connecticut
Waterbury : Biomedical Research Alliance of New York
Asthma
View More »
New Haven : Updated
A Non-drug Study Profiling Asthma
New Haven : Yale University Center for Asthma and Airway Disease
Bronchial Thermoplasty in Severe Persistent Asthma
New Haven : Investigational Site Number 840026 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
New Haven, : Yale Medical School
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Waterbury : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Waterbury : Waterbury Pulmonary Associates Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Florida
Aventura : Florida Center for Allergy and Asthma Research
12 week dose ranging study to evaluate the efficacy and safety of Fluticasone Propionate Spiromax administered twice daily compared with placebo in adolescents and adults with persistent asthma uncontrolled on non-steroidal therapy
Miami : Florida Center for Allergy and Asthma Research
12 week dose ranging study to evaluate the efficacy and safety of Fluticasone Propionate Spiromax administered twice daily compared with placebo in adolescents and adults with persistent asthma uncontrolled on non-steroidal therapy
Panama City : Emerald Coast Research Associates
Research study for Asthma
View More »
Aventura : Call for Information (Investigational Site 1009)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Aventura : Teva Investigational Site 10137 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Aventura : Teva Investigational Site 10153 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Aventura : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Bradenton : Call for Information (Investigational Site 1001)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Clearwater : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Clearwater : Saint Francis Sleep Allergy and Lung Institute Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Clearwater : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Clearwater : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Cocoa : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Coral Gables : Call for Information (Investigational Site 1144)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Debary : Omega Research Consultants LLC Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Fort Walton Beach : All Seasons Allergy and Asthma Center, P.A.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Hialeah : Call for Information (Investigational Site 1003)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Hialeah : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Jacksonville : Nemours Children's Clinic
Genotype Stratified Pharmacokinetic Study of Montelukast
Jacksonville : Nemours Children's Clinic
Long-acting Beta Agonist Step Down Study
Jacksonville : Nemours Children's Clinic
Transporter Mediated Uptake of Montelukast
Kissimmee : Call for Information (Investigational Site 1000)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Largo : Innovative Research of West Florida Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lehigh Acres : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Miami : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Miami : Call for Information (Investigational Site 1115)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Miami : Call for Information (Investigational Site 1154)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Miami : Call for Information (Investigational Site 1202)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Miami : Call for Information (Investigational Site 1259)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Miami : Community Research Foundation Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Kendall South Medical Center, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Florida Center for Allergy and Asthma Research Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Kendall South Medical Center, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Pulmonary Human Research Laboratory, University of Miami, Miller School of Medicine
Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide
Miami : Research Site Updated
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Miami : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
North Miami Beach : Novartis Investigative Site
A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
Ocala : Call for Information (Investigational Site 1062)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Ocala : Teva Investigational Site 10171 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Opalocka : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Orange City : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Orlando : GSK Investigational Site
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Port Charlotte : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sarasota : Teva Investigational Site 10178 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sarasota : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
South Miami :
AMG 761 in Adults With Asthma
South Miami : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
South Miami : Prestige Clinical Research Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Tallahassee : Allergy & Asthma Diagnostic Treatment Center
A Study of ARRY-502 in Patients With Persistent Asthma
Tallahassee : Teva Investigational Site 10161 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Tallahassee : Allergy And Asthma Dtc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tallahassee : Investigational Site Number 840044 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Tampa : Teva Investigational Site 10139 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Tampa : Investigational Site Number 840029 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Tampa : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Trinity : Advanced Research Institute, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Valrico : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
West Palm Beach : Palm Beach Research Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Winter Park : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Winter Park : Call for Information (Investigational Site 1102)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Georgia
Atlanta : Radiant Research - Atlanta
Clinical Research for Asthma
Atlanta : Pinnacle Trials, Inc.
Do you have both Diabetes & Asthma?
Lawrenceville : DataQuest Medical Research, LLC
Adult Asthma Study for African American Patients
Stockbridge : Clinical Research Atlanta
Do you, or does your child have asthma? The study is a clinical research study being conducted worldwide. The study is comparing a medication which is a combination of two differenct drugs (fluticasone propionate and salmeterol) to a medication that has only one drug (fluticasone propionate alone). Both the combination drug and fluticasone propionate alone are currently available by prescription outside this clinical research study.
View More »
Albany : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Albany : Georgia Pollens Clinical Research Centers Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Atlanta : Call for Information (Investigational Site 1111)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Columbus : Brookstone Centre Parkway
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Columbus : Teva Investigational Site 10111 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Columbus : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Gainesville : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Gainesville : Call for Information (Investigational Site 1254)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Gainesville : Teva Investigational Site 10180 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lawrenceville : Teva Investigational Site 10168 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lawrenceville : DataQuest Medical Research Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lawrenceville : DataQuest Medical Research Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lilburn : Allergy and Asthma Consultants PC Laboratory Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Savannah : Call for Information (Investigational Site 1105)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Savannah : Aeroallergy Research Labs Of Savannah, Inc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Savannah : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Idaho
Couer D'Alene : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Eagle : Idaho Research
A Study of ARRY-502 in Patients With Persistent Asthma
Meridian : Call for Information (Investigational Site 1053)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Meridian : Teva Investigational Site 10116 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Twin Falls : Call for Information (Investigational Site 1051)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Illinois
River Forest : Asthma and Allergy Center of Chicago, SC
Asthma Research for adult asthmatics using daily asthma medications (ICS)
River Forest : Asthma and Allergy Center of Chicago, SC
Research study for people with uncontrolled severe Asthma. If you are taking inhaled corticosteroids, need to use rescue several times a week and if you have been sick with asthma worsening more than two times during last year; you may be eligible to participate in our asthma study.
View More »
Chicago : Rush University Medical Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Chicago : University of Chicago
Bronchial Thermoplasty in Severe Persistent Asthma
Chicago : Rush University Medical Center
Coping Peer Intervention for Adherence
Chicago : Cedar-Crosse Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Chicago : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Decatur : Call for Information (Investigational Site 1044)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
DeKalb : Northern Illinois Research Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Hinsdale : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Normal : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Normal : Call for Information (Investigational Site 1005)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Normal : Sneeze, Wheeze & Itch
A Study of ARRY-502 in Patients With Persistent Asthma
Normal : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
River Forest : Asthma & Allergy Center of Chicago
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
River Forest : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Shiloh : Clinical Research Center of Southern Illinois, LLC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Skokie : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Springfield : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Indiana
Evansville : Call for Information (Investigational Site 1148)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Evansville : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Indianapolis : Clinical Research Center of Indiana
A Study of ARRY-502 in Patients With Persistent Asthma
Indianapolis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Albany : Nassim, McMonigle, Mescia & Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
View More »
South Bend : Call for Information (Investigational Site 1119)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
South Bend : Teva Investigational Site 10127 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Iowa
Iowa City : Updated
A Non-drug Study Profiling Asthma
Iowa City : University of Iowa Hospitals and Clinics
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Iowa City : Call for Information (Investigational Site 1122)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Iowa City : Iowa Clinical Research Corporation Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Iowa City : University of Iowa
Bronchial Thermoplasty in Severe Persistent Asthma
View More »
Iowa City : Investigational Site Number 840038 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Iowa City : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Iowa City : Iowa Clinical Research Corportation
Safety Study in Adolescent and Adult Patients With Asthma
Kansas
Overland Park : Radiant Research - Kansas City
Clinical Research for Asthma
View More »
Lenexa : Call for Information (Investigational Site 1134)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Lenexa : College Park Family Care Center Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Overland Park : Investigational Site Number 840021 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Topeka : Call for Information (Investigational Site 1143)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Topeka : Call for Information (Investigational Site 1082)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Topeka : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Kentucky
Lexington : University of Kentucky Chandler Medical Center
Assessment of Breathing in Individuals With Vocal Cord Dysfunction
Lexington : Central Kentucky Research Associates
Asthma
Lexington : University of Kentucky Chandler Medical Center
Asthma Volunteers Needed for Research Study
Lexington : University of Kentucky Chandler Medical Center
Have You Been Diagnosed With Asthma?
View More »
Lexington : University of Kentucky Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Louisville : Family Allergy and Asthma Research Institute
A Study of ARRY-502 in Patients With Persistent Asthma
Louisville : Family Allergy and Asthma Research Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Louisville : Kosair Children's Hospital
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
Owensboro : Call for Information (Investigational Site 1097)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Owensboro : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Owensboro : Allergy & Asthma Specialists, PSC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Louisiana
Lafayette : Bendel Medical Research Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Metairie :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Metairie : Teva Investigational Site 10113 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Metairie : Clinical Research Specialists Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Metairie : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
View More »
Metairie : Vectura Clinical Trial Site 10002
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Metarie : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Orleans : LSU Health Sciences
Bronchial Thermoplasty in Severe Persistent Asthma
Sunset : Call for Information (Investigational Site 1157)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Sunset : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Maine
Bangor : Teva Investigational Site 10164 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bangor : Paul Shapero's Private Practice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bangor : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Maryland
Baltimore : Johns Hopkins Asthma and Allergy Center
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
Baltimore : Updated
A Non-drug Study Profiling Asthma
Baltimore : Chesapeake Clinical Research Inc
A Study of ARRY-502 in Patients With Persistent Asthma
Baltimore : Johns Hopkins Asthma and Allergy Center
Effect of Anti-IgE in Non-Allergic Asthma
Baltimore : Investigational Site Number 840014 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
View More »
Baltimore : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bethesda : NIH Clinical Center
A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Bethesda : Teva Investigational Site 10158 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bethesda : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Largo : Teva Investigational Site 10110 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Salisbury : Call for Information (Investigational Site 1011)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Wheaton : Teva Investigational Site 10177 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Massachusetts
Boston : Brigham and Women's Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Boston : St. Elizabeth's Medical Center
Bronchial Thermoplasty in Severe Persistent Asthma
Brockton : Call for Information (Investigational Site 1055)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Burlington : Lahey Clinic
Bronchial Thermoplasty in Severe Persistent Asthma
North Dartmouth : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
View More »
North Dartmouth : North Dartmouth Clincial Site 150
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
North Dartmouth : Northeast Medical Research Associates
A Study of ARRY-502 in Patients With Persistent Asthma
North Dartmouth : Teva Investigational Site 10146 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
North Dartmouth : Teva Investigational Site 10138 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
North Dartmouth : Investigational Site Number 840015 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
North Dartmouth : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
North Dartmouth : Northeast Medical Research Associates, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
North Dartmouth : Infinity Medical Research, Inc. Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Michigan
Ann Arbor : ClinSite, LLC
Diagnosed with Asthma?
View More »
Ann Arbor : University of Michigan
Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity
Detroit : Henry Ford Hospital
Bronchial Thermoplasty in Severe Persistent Asthma
Grand Blanc : Grand Blanc Medical
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Grand Rapids : Spectrum Health Hospitals
Bronchial Thermoplasty in Severe Persistent Asthma
Kalamazoo : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
St Clair Shores : Call for Information (Investigational Site 1002)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Minnesota
Chaska : Ridgeview Research
Asthma
Minneapolis : Clinical Research Institute, MN
ADOLESCENT ASTHMA RESEARCH STUDY_678
Minneapolis : Clinical Research Institute, MN
Adult Asthma Research Study_707
Minneapolis : Clinical Research Institute, MN
Asthma Research Study for Adolescents & Adults_712
View More »
Minneapolis : Call for Information (Investigational Site 1090)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Minneapolis : Clinical Research Institute
A Study of ARRY-502 in Patients With Persistent Asthma
Minneapolis : Teva Investigational Site 10131 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Minneapolis : Clinical Research Institute Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Minneapolis : Investigational Site Number 840003 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Minneapolis : Investigational Site Number 840010 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Minneapolis : CRI
Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device
Minneapolis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Minneapolis : Clinical Research Institute, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Plymouth : Call for Information (Investigational Site 1079)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Plymouth : Clinical Research Institute
A Study of ARRY-502 in Patients With Persistent Asthma
Plymouth : 205.444.01004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Plymouth : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Plymouth : Clinical Research Institute, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
St. Paul : HealthPartners Specialty Center, Lung and Sleep Health
Bronchial Thermoplasty in Severe Persistent Asthma
Mississippi
Vicksburg : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Missouri
Creve Coeur : The Clinical Research Center, LLC
Asthmatics, do you use a maintenance inhaler on a daily basis? Have you taken Prednisone in the past 12 months to treat your asthma? If so, you may qualify for an asthma research study.
Creve Couer : The Clinical Research Center, LLC Updated New
Have you been using a maintenance inhaler to treat your asthma for the last 6 months? If so you may qualify for an asthma research study.
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
A Washington University asthma study seeks volunteers 12 - 75 years of age.
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
A Washington University asthma study seeks volunteers that take Advair, Dulera or Symbicort for their asthma.
Saint Louis : Washington University
Are you taking Xolair?
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Asthma patients! Do you use controller medications to treat your asthma?
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Female Asthmatics! Washington University seeks female asthmatics for a research study looking at the effects of an asthma medication!
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have a runny, stuffy nose or sinus infection or inflammation?
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have asthma? Are you interested in taking Vitamin D?
St Louis : Washington University in St. Louis - Center for Clinical Studies
Asthma Study Seeks Volunteers!
St Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Asthmatics! Washington University seeks asthmatics for a research study using an add-on treatment study medication.
St Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Asthmatics! Washington University seeks participants for a research study on severe asthma.
St Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have asthma?
St Louis : Washington University in St. Louis - Center for Clinical Studies
Do you use daily inhaled corticosteroids?
St. Louis : Midwest Clinical Research LLC
Asthma Clinical Trial
St. Louis : Radiant Research - St. Louis
Clinical Research Study for Asthma
St. Louis : The Clinical Research Center, LLC Updated New
Do you have asthma and allergies have been treated with prednisone in the last 18 months? If so you may qualify for an asthma study.
St. Louis : The Clinical Research Center, LLC
We are seeking volunteers to evaluate an investigational combination inhaler to treat asthma.
View More »
Bridgeton : Craig A. Spiegel MD
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Columbia : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Columbia : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Columbia : 205.444.01005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Kansas City : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Ozark : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rolla : Call for Information (Investigational Site 1092)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Rolla : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rolla : Clinical Research Of The Ozarks, Inc. Laboratory Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Saint Louis :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
St Louis : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
St Louis : Investigational Site Number 840006 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
St Louis : Investigational Site Number 840013 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
St. Louis : Call for Information (Investigational Site 1086)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
St. Louis : Call for Information (Investigational Site 1152)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
St. Louis : Teva Investigational Site 10175 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
St. Louis : Washington University School of Medicine Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Louis : The Clinical Research Center, L.L.C. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Louis : Washington University School of Medicine
Bronchial Thermoplasty in Severe Persistent Asthma
St. Louis : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
St. Louis : GSK Investigational Site Updated
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
St. Louis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
St. Louis : The Clinical Research Center, LLC
Safety Study in Adolescent and Adult Patients With Asthma
St. Louis : Medex Healthcare Research, Inc. Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
St. Louis : Midwest Clinical Research, LLC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Warrensburg : Call for Information (Investigational Site 0118)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Warrensburg : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Montana
Missoula : Montana Medical Research, Inc.
Have you been diagnosed with Asthma?
View More »
Billings : Call for Information (Investigational Site 1113)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Billings : Billings Clinic Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Boseman : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bozeman : Clinical Research Group of Montana
A Study of ARRY-502 in Patients With Persistent Asthma
Bozeman : Clinical Research Group of Montana
Safety Study in Adolescent and Adult Patients With Asthma
Missoula : Call for Information (Investigational Site 1063)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Nebraska
Bellevue : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Bellevue : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bellevue : The Asthma & Allergy Center
A Study of ARRY-502 in Patients With Persistent Asthma
Bellevue : Teva Investigational Site 10118 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bellevue : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Bellevue : The Asthma & Allergy Center, PC
Safety Study in Adolescent and Adult Patients With Asthma
Boys Town : Boys Town National Research Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Omaha : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Omaha : Creighton University Medical Center (CUMC) (Saint Joseph Hospital)
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Omaha : Teva Investigational Site 10150 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Omaha : Midwest Allergy and Asthma Clinic Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Omaha : Investigational Site Number 840025 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Omaha : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Papillion : Investigational Site Number 840008 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Papillon : The Asthma And Allergy Center, Pc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Papillon : The Asthma And Allergy Center, Pc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nevada
Las Vegas : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
New Jersey
Edison : Anderson & Collins Clinical Research, Inc.
Asthma Research Study
View More »
Berlin : Call for Information (Investigational Site 1050)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Brick : Teva Investigational Site 10114 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Brick : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Brick : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Cedar Knolls : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Hillsborough : Teva Investigational Site 10101 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Ocean : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Princeton : Princeton Clinical Site 170
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
Princeton : Investigational Site Number 840018 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Skillman : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Skillman : Princeton Center for Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Skillman : Teva Investigational Site 10155 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Skillman : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Skillman : Princeton Center for Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
West Orange : Teva Investigational Site 10188 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
New Mexico
Albuquerque : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Albuquerque : New Mexico Clinical Research & Osteoporosis Center Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
New York
Bronx : Biomedical Research Alliance of New York
Asthma
Bronx : Biomedical Research Alliance of New York
Asthma
Bronx : Biomedical Research Alliance of New York
Asthma
Mineola : Winthrop University Hospital Clinical Trials Center
Asthma Study - Are You Taking Xolair
New Hyde Park : Biomedical Research Alliance of New York, LLC
Symbicort treatment for patients with asthma
New York : Biomedical Research Alliance of New York, LLC
Symbicort treatment for patients with asthma
Rochester : AAIR Research Center
Attention Those With Asthma: We Understand the Difficulties of Living with Asthma.
Rochester : AAIR Research Center
Does Your Child Suffer From Asthma? The triggers for asthma are all around us-colds, pets, pollen, pollution and even the weather.
Rochester : AAIR Research Center
Losing Control of Asthma Can Keep People From Doing the Things They Enjoy.
Rochester : AAIR Research Center
Seeking Volunteers with Asthma for an Investigational New Research Study
Rochester : AAIR Research Center
Study to compare the safety and effectiveness of Symbicort delivered via two different inhalers and Budesonide. The two inhalers are a breath actuated metered dose inhaler and a pressurized metered dose inhaler.
View More »
Albany : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Bronx : Bronx Medical Center for Pulmonary, Asthma and Sleep Disorde Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brooklyn : Maimonides Medical Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Brooklyn : Call for Information (Investigational Site 1112)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Great Neck : North Shore-Long Island Jewish Health System, Division of Allergy/Immunology
The Effect of Montelukast on Asthma Control in Obese Asthmatic Children and Adolescents
Mineola : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Hyde Park : North Shore Diabetes and Endocrine Associates
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New Hyde Park : Hofstra North Shore-LIJ School of Medicine
Long-acting Beta Agonist Step Down Study
New York : Teva Investigational Site 10120 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
New York : MedHex Health
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : New York University School of Medicine
Long-acting Beta Agonist Step Down Study
New York : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Newburgh : Call for Information (Investigational Site 1153)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Newburgh : Teva Investigational Site 10190 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Newburgh : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Newburgh : ENT and Allergy Associates, LLP Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
North Syracuse : Call for Information (Investigational Site 1060)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
North Syracuse : Teva Investigational Site 10167 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rochester : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Rochester : Call for Information (Investigational Site 0115)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Rochester : Teva Investigational Site 10112 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rochester : AAIR Research Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rochester : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Utica : St. Elizabeth Health Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
North Carolina
Cary : PMG Research of Cary
Do you have Asthma?
Wilmington : PMG Research of Wilmington
Do you have Asthma?
Winston-Salem : PMG Research of Winston-Salem
Do you have Asthma?
View More »
Charlotte : American Health Research, Inc. Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Durham : Duke University
Bronchial Thermoplasty in Severe Persistent Asthma
Greensboro : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Greensboro : Call for Information (Investigational Site 1257)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
High Point : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
High Point : Call for Information (Investigational Site 1263)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
High Point : Teva Investigational Site 10105 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
High Point : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Raleigh : Raleigh Clinical Site 130
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
Raleigh : North Carolina Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Raleigh : Call for Information (Investigational Site 0117)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Raleigh : Teva Investigational Site 10122 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Raleigh : Novartis Investigative Site
A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
Raleigh : Novartis Investigative site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Raleigh : North Carolina Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
Winston Salem : Investigational Site Number 840004 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Winston-Salem : Wake Forest University Health Sciences Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Winston-Salem : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
North Dakota
Fargo : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Ohio
Akron : Radiant Research - Akron
Clinical Research for Asthma
View More »
Akron : Call for Information (Investigational Site 1083)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Canton : Call for Information (Investigational Site 1104)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Canton : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Carlisle : Call for Information (Investigational Site 1061)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Cincinnati : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Cincinnati : Cincinnati Children's Hospital Medical Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Cincinnati : Call for Information (Investigational Site 0106)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Cincinnati : Teva Investigational Site 10107 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Cincinnati : Teva Investigational Site 10123 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Cincinnati : New Horizons Clinical Research Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Cincinnati : Bernstein Clinical Research Center, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cincinnati : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Cincinnati : 205.444.01001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Cincinnati : New Horiznons Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
Cleveland : Updated
A Non-drug Study Profiling Asthma
Cleveland : MetroHealth Medical Center
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
Cleveland : Cleveland Clinic Foundation
Bronchial Thermoplasty in Severe Persistent Asthma
Cleveland : The Cleveland Clinic
Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing
Columbus : Call for Information (Investigational Site 1056)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Columbus : Teva Investigational Site 10144 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Columbus : Optimed Research, LTD Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Columbus : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Dayton : Dayton Clinical Research
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Dayton : Call for Information (Investigational Site 1010)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Marion : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Middleburg Heights : HCCA Clinical Research Solutions Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Sylvania : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Sylvania : Call for Information (Investigational Site 1261)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Sylvania : Toledo Center for Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Sylvania : Investigational Site Number 840023 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Sylvania : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Oklahoma
Norman : Ekips Technologies, Inc.
Development of a Breath Analyzer for Asthma Screening
Oklahoma City : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Oklahoma City : Allergy, Asthma and clinical Research Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Oklahoma City : Eminence Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Oklahoma City : Call for Information (Investigational Site 1058)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
View More »
Oklahoma City : Teva Investigational Site 10160 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Oklahoma City : Teva Investigational Site 10174 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Oklahoma City : Allergy, Asthma & Clinical Research Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Oklahoma City : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Oklahoma City : Investigational Site Number 840045 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Oklahoma City : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Oklahoma City : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Oklahoma City : Integrity People Services Research Company Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Tulsa : Vital Prospects Clinical Research Institute
Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device
Tulsa : Vital Prospects Clinical Research Institute, PC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Oregon
Ashland : Integrated Medical Research, PC
Safety Study in Adolescent and Adult Patients With Asthma
Ashland : Integrated Medical Research, PC Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Eugene : Teva Investigational Site 10132 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Eugene : Allergy and Asthma Research Group
Safety Study in Adolescent and Adult Patients With Asthma
Lake Oswego : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
View More »
Lake Oswego : Baker Allergy, Asthma & Dermatology Research Center
A Study of ARRY-502 in Patients With Persistent Asthma
Lake Oswego : Investigational Site Number 840001 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Lake Oswego : Baker Allergy, Asthma and Dermatology Research Center, LLC
Safety Study in Adolescent and Adult Patients With Asthma
Medford : Call for Information (Investigational Site 1201)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Medford : Clinical Research Institute of Southern Oregon
A Study of ARRY-502 in Patients With Persistent Asthma
Medford : Teva Investigational Site 10135 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Medford : Clinical Research Institute of Southern Oregon, PC Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Medford : Amphastar Site 2
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
Medford : Investigational Site Number 840012 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Medford : GSK Investigational Site Updated
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Medford : Amphastar Site 2
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Medford : The Clinical Research Institute of Southern Oregon, PC
Safety Study in Adolescent and Adult Patients With Asthma
Portland : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Portland : Call for Information (Investigational Site 1109)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Portland : Teva Investigational Site 10142 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Portland : Investigational Site Number 840016 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Portland : Amphastar Site 1
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Portland : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Portland : Allergy Associates Research Center
Safety Study in Adolescent and Adult Patients With Asthma
Pennsylvania
Blue Bell : Allergy & Asthma Specialists, P.C.
Currently enrolling asthmatics that are not well controlled on current asthma therapy.
Pittsburgh : Primary Physicians Research
Intermittent and Daily Treatment for Episodic Asthma
View More »
Altoona : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Altoona : Central PA Asthma and Allergy Care, LLC Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bethlehem : Call for Information (Investigational Site 1114)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Blue Bell : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Blue Bell : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Feasterville : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Hershey : Pennsylvania State Hershey
Bronchial Thermoplasty in Severe Persistent Asthma
Levittown : Call for Information (Investigational Site 1133)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Philadelphia : Updated
A Non-drug Study Profiling Asthma
Philadelphia : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Philadelphia : Call for Information (Investigational Site 1077)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Philadelphia : Teva Investigational Site 10183 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Philadelphia : University of Pennsylvania
Bronchial Thermoplasty in Severe Persistent Asthma
Philadelphia : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Phoenixville : Call for Information (Investigational Site 1120)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Pittsburgh : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Pittsburgh : Teva Investigational Site 10166 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Pittsburgh : Investigational Site Number 840037 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Pittsburgh : Research Site Updated
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Pittsburgh : University of Pittsburgh
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
Pittsburgh : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Upland : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Upland : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Upland : Asthma and Allergy Research Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Upland : Call for Information (Investigational Site 1103)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Upland : Teva Investigational Site 10121 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Upland : Investigational Site Number 840009 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Wyomissing : Call for Information (Investigational Site 1137)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Rhode Island
East Providence : Call for Information (Investigational Site 1059)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Lincoln : Teva Investigational Site 10181 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lincoln : Asthma & Allergy Physicians of Rhode Island Clinical Researc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lincoln : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Providence : Teva Investigational Site 10162 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
Providence : Asthma, Nasal Disease & Allergy Research Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
South Carolina
Greer : Radiant Research - Greer
Asthma Research Study
View More »
Charleston : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Charleston : AAC Research - PC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Charleston : National Allergy, Asthma, and Uticaria Centers
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Charleston : Call for Information (Investigational Site 1126)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Charleston : Teva Investigational Site 10149 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charleston : Teva Investigational Site 10126 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charleston : Asthma & Allergy Consultants, LLP Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Charleston : Medical University of South Carolina
Bronchial Thermoplasty in Severe Persistent Asthma
Charleston : 205.444.01002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Charleston : 205.444.01012 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Charleston : Investigational Site Number 840027 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Easly : Call for Information (Investigational Site 1142)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Florence : Clinical Research Associates Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Fort Mill : Piedmont Research Partners LLC Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Greenville : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Greenville : ADAC Research, PA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Mt. Pleasant : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
North Charleston : Amphastar Site 7
Evaluation of Efficacy and Safety of E004 in Children With Asthma
North Charleston : National Allergy, Asthma and Urticaria Centers of Charleston, P.A.
Safety Study in Adolescent and Adult Patients With Asthma
Orangeburg : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Orangeburg : Sterling ENT/Carolina Research Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Spartanburg : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Spartanburg : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Spartanburg : GSK Investigational Site Updated
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Spartanburg : Spartanburg Medical Research Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Spartanburg : S. Carolina Pharmaceutical Research Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Tennessee
Bristol : PMG Research of Bristol
Do you have Asthma?
View More »
Chattanooga : The Asthma Institute, PLLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Kingsport : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Nashville : Vanderbilt University Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Texas
Dallas : Radiant Research - Dallas, North
Asthma Research Study
Dallas : Pharmaceutical Research & Consulting, Inc.
Do you have asthma?
Dallas : ACRC TRIALS
DO YOU HAVE ASTHMA?
Plano : ACRC TRIALS
Attention Asthma Sufferers!
Are you a female that suffers from Asthma?
San Antonio : Women's Diagnostics
Clinical research study for patients with Asthma
San Antonio : Allergy Diagnostics
Clinical research study for patients with Asthma
San Antonio : Diagnostics Research Group
Clinical research study for patients with Asthma
San Antonio : Women's Diagnostics
Clinical research study for patients with Asthma
San Antonio : Diagnostics Research Group
Clinical research study for patients with Asthma
San Antonio : Lung Diagnostics, LTD
Clinical research study for patients with Asthma
San Antonio : Lung Diagnostics, LTD
Clinical research study for patients with Asthma
San Antonio : Allergy Diagnostics
Clinical research study for patients with Asthma
San Antonio : Lung Diagnostics
Clinical research study for patients with Moderate-Severe Asthma
Waco : Allergy Asthma Research Institute
A randomized, double-blind with open-lable active comparator, parallel group, multi-center study to evaluate the safety of once daily fluticasone furoate/XXX inhaled powder for 52 weeks in adult and adolescent subjects with asthma.
Waco : Allergy Asthma Research Institute
Adult Asthma Study
Waco : Allergy Asthma Research Institute
Do you suffer from Asthma?
Waco : Allergy Asthma Research Institute
Infants and toddlers with asthma symptoms (coughing, wheezing, shortness of breath).
Waco : Allergy Asthma Research Institute
Pediatric Asthma Study
View More »
Austin : Isis Clinical Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Austin : Sirius Clinical Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Benbrook : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Boerne : TTS Research
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Boerne : Call for Information (Investigational Site 0110)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Boerne : Teva Investigational Site 10119 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Boerne : Allergy and Asthma Center of Boerne Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Corsicana : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Dallas : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Dallas : Dallas Allergy Immunology Research
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Dallas : Call for Information (Investigational Site 1046)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Dallas : Call for Information (Investigational Site 1136)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Dallas : Pharmaceutical Research & Consulting Inc.
A Study of ARRY-502 in Patients With Persistent Asthma
Dallas : Teva Investigational Site 10141 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Dallas : Allergy/Immunology Research Center of North Texas Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Dallas : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Dickinson : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
El Paso : Call for Information (Investigational Site 1085)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
El Paso : Western Sky Medical Research Inc
A Study of ARRY-502 in Patients With Persistent Asthma
El Paso : Teva Investigational Site 10148 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
El Paso : Western Sky Medical Research Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
El Paso : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
El Paso : Western Sky Medical Research
Comparing Bronchodilation of Symbicort With and With Out Valved Holding Chamber (Aerochamber Plus)
El Paso : 205.444.01013 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
El Paso : Investigational Site Number 840030 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
El Paso : Amphastar Site 3
Evaluation of Efficacy and Safety of E004 in Children With Asthma
El Paso : Allergy and Asthma Center of El Paso
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
El Paso : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
El Paso : Western Sky Medical Research
Safety Study in Adolescent and Adult Patients With Asthma
Fort Worth : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Fort Worth : Call for Information (Investigational Site 1080)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Fort Worth : Call for Information (Investigational Site 0119)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Fort Worth : North Texas Institute for Clinical Trials Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Fort Worth : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Galveston : Updated
A Non-drug Study Profiling Asthma
Galveston : William Calhoun, MD
Bronchial Thermoplasty in Severe Persistent Asthma
Houston : Pioneer Research Solutions, Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Houston : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Houston : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Katy : Breath of Life Research Institute
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Killen : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Live Oak : Live Oak Allergy and Asthma Clinic
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Live Oak : Live Oak Allergy & Asthma Clinic Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
New Braunfels : New Braunfeis Clinical Site 120
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
New Braunfels : Central Texas Health Research
A Study of ARRY-502 in Patients With Persistent Asthma
New Braunfels : Amphastar Site 3
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
New Braunfels : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Braunfels : Central Texas Health Research
Safety Study in Adolescent and Adult Patients With Asthma
Round Rock : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
San Antonio : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
San Antonio : San Antonio Clinical Site 180
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
San Antonio : Quality Assurance Research Center, Inc.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
San Antonio : Sylvana Research Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
San Antonio : Southwest Allergy and Asthma, P.A.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
San Antonio : Call for Information (Investigational Site 1135)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
San Antonio : Call for Information (Investigational Site 1076)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
San Antonio : Sylvana Research Associates
A Study of ARRY-502 in Patients With Persistent Asthma
San Antonio : Call for Information (Investigational Site 0108)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
San Antonio : Call for Information (Investigational Site 0113)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
San Antonio : Teva Investigational Site 10115 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Antonio : Southwest Allergy and Asthma Research Center, P. A. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Alamo Clinical Research Associates Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Alamo Clinical Research Associates Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Amphastar Site 4
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
San Antonio : Investigational Site Number 840050 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
San Antonio : SAM Clinical Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
San Antonio : Amphastar Site 6
Evaluation of Efficacy and Safety of E004 in Children With Asthma
San Antonio : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
San Antonio : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Antonio : Innovative Clinical Trials Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Sugarland : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Waco : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Waco : Allergy & Asthma Care of Waco
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Waco : Call for Information (Investigational Site 0101)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Waco : Teva Investigational Site 10103 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Waco : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Waco : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Utah
Salt Lake City : Optimum Clinical Research, Inc.
Asthma. Prevention of asthma related complications.
West Jordan : Advanced Clinical Research, UT Updated New
Have You Been Diagnosed With Asthma?
View More »
Bountiful : Call for Information (Investigational Site 1048)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Draper : Call for Information (Investigational Site 1106)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Draper : Vectura Clinical Trial Site 10004
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Salt Lake City : Call for Information (Investigational Site 1204)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Vermont
Colchester : University of Vermont
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
South Burlington : Teva Investigational Site 10134 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
South Burlington : 205.444.01003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
South Burlington : Investigational Site Number 840052 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
South Burlington : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Virginia
Richmond : Pulmonary Associates of Richmond, Inc.
Asthma takes the air out of your game.
View More »
Abingdon : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Burke : PI-Coor Clinical Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Burke : Teva Investigational Site 10159 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charlottesville : University of Virginia Medical Center
Bronchial Thermoplasty in Severe Persistent Asthma
Charlottesville : University of Virginia
Long-acting Beta Agonist Step Down Study
Colonial Heights : Colonial Heights Pediatrics
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Newport News : Call for Information (Investigational Site 1132)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Richmond : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Richmond : Call for Information (Investigational Site 1088)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Richmond : Call for Information (Investigational Site 0107)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Richmond : Teva Investigational Site 10108 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Richmond : Virginia Commonhealth University Health System Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Richmond : Pulmonary Associates of Richmond
Bronchial Thermoplasty in Severe Persistent Asthma
Richmond : Investigational Site Number 840049 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Richmond : Allergy Partners, PA/VA Adult and Pediatric Allergy and Asthma, P.C.
Safety Study in Adolescent and Adult Patients With Asthma
Richmond : Pulmonary Associates Of Richmond, Inc. Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Washington
Bellingham : Bellingham Asthma, Allergy, & Immunology Clinic
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Kirkland : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seattle : Asthma Inc.
A Study of ARRY-502 in Patients With Persistent Asthma
Seattle : Investigational Site Number 840020 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Seattle : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Seattle : ASTHMA, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Spokane : Teva Investigational Site 10124 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Spokane : Marycliff Allergy Specialists PS Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Tacoma : Franciscan Research Center (St. Joseph Medical Center)
Bronchial Thermoplasty in Severe Persistent Asthma
Tacoma : MultiCare Pulmonary Specialists
Bronchial Thermoplasty in Severe Persistent Asthma
Tacoma : Investigational Site Number 840019 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Tacoma : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Wisconsin
Greenfield : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Greenfield : Allergy Asthma & Sinus Center, S.C.
A Study of ARRY-502 in Patients With Persistent Asthma
Greenfield : Teva Investigational Site 10170 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Greenfield : Allergy Asthma & Sinus Center Updated
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Madison : University of Wisconsin-Madison Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Madison : University of Wisconsin
Bronchial Thermoplasty in Severe Persistent Asthma
Madison : Investigational Site Number 840034 Updated
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Madison : University of Wisconsin Madison Department of Asthma, Allergy and Pulmonary Clinical Research
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
Milwaukee : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Milwuakee : Call for Information (Investigational Site 1049)
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Argentina
Capital Federal : 205.456.54006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Capital Federal : 205.456.54002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Ciudad Autonoma de Buenos Aire : Organización Médica de Investigación Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Ciudad Autonoma de Buenos Aire : Fundacion CIDEA, Sanatorio San Jose Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Ciudad Autonoma de Buenos Aire : Organización Médica de Investigación Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Ciudad Autonoma de Buenos Aire : Fundacion CIDEA, Sanatorio San Jose Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Florencio Varela : 205.456.54003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mendoza : 205.456.54005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Quilmes-Buenos Aires : Centro Respiratorio Quilmes Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rosario : Centro Respiratorio Infantil Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rosario-Santa Fe : Sanatorio Parque de Rosario Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rosario-Santa Fe : Sanatorio Parque de Rosario Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucumán : 205.456.54004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
San Miguel de Tucuman - Tucuma : Centro Médico Dra De Salvo Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucuman - Tucuma : Centro Modelo de Cardiologia Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucuman - Tucuma : Investigaciones en Patologias Respiratorias Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucuman - Tucuma : Centro Médico Dra De Salvo Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Australia
Clayton : Monash Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Daw Park : Repatriation General Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Frankston : Frankston Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Liverpool : Liverpool Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Melbourne : The Alfred Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Nedlands : Lung Institute of Western Australia Inc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Randwick : GSK Investigational Site
A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol
Belgium
Brussels : GSK Investigational Site
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
Bruxelles : Cliniques Universitaires Saint-Luc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bruxelles : Hôpital Erasme Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bruxelles : Cliniques Universitaires Saint-Luc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bruxelles : Hôpital Erasme Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Gent : UZ Gent Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Gent : UZ Gent Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Jambes : Docteur Jean-Benoit Martinot Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Liège : CHU de Liège Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Liège : CHU de Liège Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brazil
Belo Horizonte : Santa Casa de Belo Horizonte Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Belo Horizonte : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Florianopolis : Nucleo de Pesquisa em Asma e Inflamaçao das Vias Aereas Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Florianopolis : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Goiânia : Hospital Geral de Goiânia Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Porto Alegre : Hospital São Lucas da PUC - RS Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Hospital de Clínicas de Porto Alegre Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Hospital São Lucas da PUCRS Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Hospital Nossa Senhora da Conceição Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Porto Alegre - RS : Hospital Moinhos de Vento Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre, RS : Irmandade da Santa Casa de Misericordia de Porto Alegre Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre-RS : Hospital de Clinicas de Porto Alegre Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rio de Janeiro : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Salvador : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Santo André, São Paulo : Fundação do ABC - Faculdade de Medicina do ABC Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Santo André, São Paulo : Fundação do ABC - Faculdade de Medicina do ABC Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Sao Paulo : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Vitoria : CEDOES- DIagnóstico e Pesquisa do Espírito Santo Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bulgaria
Burgas : Teva Investigational Site 59107 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lovech : Teva Investigational Site 59103 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Pleven : Teva Investigational Site 59106 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Plovdiv : 205.456.35902 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Plovdiv : UMHAT "Alexandrovska
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
View More »
Ruse : Teva Investigational Site 59104 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Ruse : 205.456.35901 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Sofia : Teva Investigational Site 59101 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sofia : Teva Investigational Site 59102 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sofia : Teva Investigational Site 59105 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sofia : 205.456.35903 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Canada
Calgary : Updated
A Non-drug Study Profiling Asthma
Calgary : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Calgary : University of Calgary Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Calgary : University of Calgary Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Edmonton : University of Alberta Hospital
Tiotropium for Smoking Asthmatics Study
View More »
Montreal : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Montreal : Hopital du Sacre Couer de Montreal Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Montreal : Montreal Chest Institute
Bronchial Thermoplasty in Severe Persistent Asthma
Newmarket : SKDS Research Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Newmarket : SKDS Research Inc. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ottawa : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Pointe-Claire : Dynamik Research Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quebec : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Sainte Foy : Updated
A Non-drug Study Profiling Asthma
Sainte-Foy : Hospital Laval Centre de Pneumologie
Bronchial Thermoplasty in Severe Persistent Asthma
Surrey : Surrey Memorial Hospital
Bronchial Thermoplasty in Severe Persistent Asthma
Toronto : The Hospital for Sick Children
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
Vancouver : Updated
A Non-drug Study Profiling Asthma
Windsor : Dr. Anil Dhar Professional Medicine Corporation Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Windsor : Dr. Anil Dhar Professional Medicine Corporation Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Chile
Puente Alto - Santiago : GSK Investigational Site Updated
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Rancagua : Hospital Regional Rancagua Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : Hospital Roberto del Rio Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : Hospital Padre Hurtado Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : Investigaciones Medicas Tasol Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Santiago : 205.444.56002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Santiago : GSK Investigational Site Updated
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Temuco : Centro Investigacion Clinica del Sur Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Valdivia : Hospital Base de Valdivia Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Valparaiso : Hospital Carlos Van Buren Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Viña del Mar : 205.444.56003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Viña del Mar : 205.444.56001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
China
Beijing : Capital Institute of Pediatrics
Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children
Beijing : The Second Artillery General Hospital of PLA
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Beijing : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Beijing : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Beijing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
View More »
Beijing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changchun : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changsha : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Changsha : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changsha City : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Chengdu : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Chongqing : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Chongqing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Foshan : The First Affiliated Hospital of Foshan
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guang zhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Guang Zhou City : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Guangzhou : The First Affiliated Hospital of Guangzhou Medical College, Guangzhou Institute of Respiratory Disease
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guangzhou : Guangzhou First Municipal People's Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guangzhou : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Guangzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Haikou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Hangzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanchang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanjing : Zhongda Hospital of Southeast University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Nanjing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanjing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Qingdao : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shanghai : Putuo District Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : Dongfang Hospital Affiliated to Tongji University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : Zhongshan Hospital affiliated to Fudan University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Shanghai : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shanghai : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shanghai : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shengyang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shenyang : Shengjing Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shenyang : The General Hospital of Shenyang Military Region
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shenyang : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Shenyang : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shenyang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shijiazhuang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Suzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Wuhan : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Xian : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Xian : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Xi'an : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Colombia
Barranquilla : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bogota : Fundación Salud Bosque Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogota : Fundación Salud Bosque Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogota : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bogotá : Fundacion Neumologica Colombiana Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Bogotá : Fundacion Neumologica Colombiana Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cali : Fundacion Clinica Valle del Lili Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Floridablanca : Fundacion Oftalmologica de Santander Foscal Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Floridablanca : Fundacion Oftalmologica de Santander Foscal Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Croatia
Split : Teva Investigational Site 85105 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Zagreb : Teva Investigational Site 85102 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Zagreb : Teva Investigational Site 85103 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Zagreb : Teva Investigational Site 85104 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Czech Republic
Boskovice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Breclav : Alergologicka ambulance Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Breclav : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Brno : HORNMED s.r.o. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brno : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Brno - Bohunice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Hradec Kralove : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jablonec nad Nisou : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jindřichův Hradec : Sdružená pneumologická a anesteziologická ambulance
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Kladno : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Kutna Hora : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Liberec : Krajska nemocnice Liberec Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Liberec : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Most : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Olomouc : Fakultni Nemocnice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ostrava : Fakultni nemocnice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Plzen : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Plzen : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Plzen - Bory : Fakultni nemocnice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Praha : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tabor : KASMED s.r.o. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tabor : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Teplice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Trutnov : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Denmark
Aarhus C : Research Dept. of Respiratory Medicine, Aarhus University Hospital
Bronchial Challenge Test of Magnesium-treated Asthmatics
Copenhagen : BørneAstmaKlinikken
Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
Hvidovre : Hvidovre Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kobenhavn Nv : Updated
A Non-drug Study Profiling Asthma
Odense : Odense universitetshospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
France
Bordeaux Pessac N/A : Updated
A Non-drug Study Profiling Asthma
Brest : CHU Cavale Blanche
Masitinib in Severe Persistent Asthma
Marseille : Updated
A Non-drug Study Profiling Asthma
Marseille cedex 20 : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Montpellier : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
View More »
Paris : Necker Enfants Malades Hospital
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Germany
Bad Wörishofen : Praxis Dr. med. Junggeburth Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Praxis Dr. Anneliese Linnhoff Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Charité - Universitätsmedizin Berlin Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Klinische Forschung Berlin Mitte GmbH Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
View More »
Berlin : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Bochum : 205.425.49005 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Bochum : 205.456.49001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Bonn : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Bretten : Drez. Gelb & Knecht
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Dresden : 205.425.49004 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Dresden : Synexus Clinical Research GmbH Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Elgershausen. Greifenstein : Lungenfachklinik Waldhof Elgershausen
Inhaled Steroids and Control of Severe Asthma
Frankfurt : Updated
A Non-drug Study Profiling Asthma
Frankfurt : IKF Pneumologie Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Frankfurt : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Frankfurt : 205.456.49004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Frankfurt am Main : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Giessen : Justus-Liebig-University Giessen
Inhaled Steroids and Control of Severe Asthma
Hannover : Clinical Airway Research Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)
Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma
Koblenz : 205.425.49002 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Koblenz : 205.456.49003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Landsberg : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Leipzig : Synexus ClinPharm GmbH Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lubeck : KLB
Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
Lübeck : Updated
A Non-drug Study Profiling Asthma
Magdeburg : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Mainz : Universitätsmedizin der Johannes Gutenberg-Universität Mainz Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mainz : Studienzentrum Mainz Mitte am GesundheitsCentrum Mainz Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mannheim : CRS Clinical Research Services Mannheim GmbH
Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects
Rosenheim : 205.425.49003 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Rüdersdorf : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Schwetzingen : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Wesel : 205.425.49001 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Wesel : 205.456.49002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Wiesbaden : Novartis Investigative site
A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device
Greece
Alexandroupolis : University General Hospital of Alexandroupolis Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Athens : Sotiria Chest hospital of Athens Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Heraklion, Crete : University General Hospital of Heraklion Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Larissa : University Hospital of Larissa Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Hungary
Balassagyarmat : Dr. Kenessey Albert Kórház-Rendelöintézet Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Balassagyarmat : Dr. Kenessey Albert Kórház-Rendelöintézet Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Balassagyarmat : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Budapest : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Budapest : Teva Investigational Site 36104 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
Budapest : 205.425.36001 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Budapest : 205.425.36003 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Budapest : 205.456.36005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Budapest : 205.444.36005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Debrecen : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Debrecen : 205.456.36002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Debrecen : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Deszk : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Gyor : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Gyula : 205.456.36004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Kiskunhalas : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Marcali : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Miskolc : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Miskolc : Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi O Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miskolc : Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi O Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miskolc : 205.456.36001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Miskolc : 205.444.36001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Mosdos : 205.425.36002 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Mosdos : 205.444.36002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Mosonmagyarovar : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Mosonmagyaróvár : Karolina Kórház Rendelöintézet Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Mosonmagyaróvár : Karolina Kórház Rendelöintézet Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nyiregyhaza : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sopron : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Sopron : Sopron Megyei Jogú Város Erzsébet Kórház a DEOEC Oktató Kórh Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Sopron : Sopron Megyei Jogú Város Erzsébet Kórház a DEOEC Oktató Kórh Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Szeged : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Szeged : 205.425.36004 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Szigetbecse : 205.444.36004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Szigetvár : Micro Care Kft
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Tatabanya : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tatabánya : Komárom-Esztergom Megyei Önkormányzat Szent Borbála Kórháza Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Torokbalint : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Torokbalint : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Törökbálint : Pest Megyei Tüdögyógyintézet Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
India
Ahmedabad : Gujarat Pulmonary & Critical Care Clinic
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bangalore : Chest and Maternity Centre
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bangalore : M S Ramaiah Medical College & Teaching Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bangalore : Narayanan Hrudayalaya Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Chennai : Chennai Thoracic Research Institute
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
View More »
Chennai : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Coimbatore : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Goa : T B and Chest Disease Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Hyderabaad : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Hyderabad : Kunal Institute of Medical Specialities Pvt. Ltd
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Indore : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jaipur : Asthma Bhawan
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Jaipur : Dr Khippal's Clinic
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Kolkata : National Allergy Asthma Bronchitis Institute
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Mangalore : Kasturba Medical College Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Mangalore : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Mumbai : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Nagpur : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Nellore : Narayana Medical College & Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Panjim : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Ponda : Rutuja Allergy , Chest and General Clinic
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Pune : Chest Research Foundation
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Vellore : Christian Medical College
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Israel
Ashkelon : Teva Investigational Site 72111 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Ashkelon : Barzilai Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Beer-Sheva : Soroka University Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Haifa : Teva Investigational Site 72101 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Haifa : Rambam Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Haifa : The Lady Davis Carmel Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Haifa : 205.456.97206 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Holon : 205.456.97205 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Jerusalem : Teva Investigational Site 72102 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Jerusalem : Teva Investigational Site 72104 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Jerusalem : Hadassah University Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Jerusalem : Shaare Zedek Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kfar Saba : Teva Investigational Site 72109 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Kfar Saba : Meir Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Petach Tikva : Rabin Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Petach Tikva : 205.456.97203 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Ramat Gan : Chaim Sheb Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ramat-Gan : Teva Investigational Site 72107 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rehovot : Teva Investigational Site 72103 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rehovot : Kaplan Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rehovot : Kaplan Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Safed : 205.456.97201 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Tel Aviv : Teva Investigational Site 72110 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Tel-Aviv : Tel Aviv Sourasky Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tel-Aviv : Tel Aviv Sourasky Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Zerifin : Teva Investigational Site 72105 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Italy
Genoa : G.Gaslini Institute
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Genova : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Japan
Fukuoka : Novartis Investigative Site
Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children
Osaka :
A Phase IIa Study of KHK4563
Tokyo : Novartis Investigative Site
Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children
Yokohama City : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Korea, Republic of
Anyang : Research Site
The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
Bucheon-si, : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Bucheon-si, : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Busan : Research Site
The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
Changwon : Research Site
The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
View More »
Cheongju, Chungcheongbuk-do : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Cheongju, Chungcheongbuk-do : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Guri : 205.444.82003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Gwangju : Chonnam National University Hospital Institutional Review Bo Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Gwangju : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Ilsanseo-gu, Goyang-si, Gyeonggi-do : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Ilsanseo-gu, Goyang-si, Gyeonggi-do : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Pusan : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Pusan : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Seongnam-si, Gyeonggi-do : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Seoul : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Seoul :
A Phase IIa Study of KHK4563
Seoul : Severance Hospital Institutional Review Board Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Kangdong Sacred Heart Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Korea University Guro Hospital IRB Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Asan Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Seoul National University Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Seoul National University Hospital
Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma
Seoul : 205.444.82004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Seoul : 205.444.82001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Seoul : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Seoul : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Seoul : Handok Pharmaceuticals
Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice
Seoul : Yuhan Corporation
Safety and Efficacy of YHD001 in Asthma
Seoul : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seoul : Novartis Investigative SIte
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seoul : Samsung medical center
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul : Seoul National University
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul : Asan Medical Center
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul : Hanyang University Hospital
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul, : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Seoul, : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Suwon : Ajou University Hospital Institutional Review Board Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Suwon : Ajou University Medical Center
Asthma Control in Elderly Patients With Montelukast
Suwon : Research Site
The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
Suwon : Ajou University Hospital
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Uijeongbu : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Wonju : Research Site
The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
Latvia
Baldone : 205.425.37101 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Baldone : 205.456.37101 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Baldone : 205.444.37101 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Balvi : 205.425.37105 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Balvi : 205.456.37104 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
View More »
Daugavpils : 205.425.37104 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Dubulti : 205.425.37106 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Ogre : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Ogre : 205.444.37102 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Rezekne : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Rezekne : 205.456.37103 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Rezekne : 205.444.37105 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Riga : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Riga : 205.425.37103 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Riga : 205.425.37102 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Riga : 205.456.37102 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Riga : 205.444.37106 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Talsi : 205.444.37103 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Tukums : 205.444.37104 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Lithuania
Kaunas : 205.425.37004 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Taurage : 205.425.37003 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Vilnius : 205.425.37001 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Vilnius : 205.425.37002 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Malaysia
Batu Caves : Universiti Teknologi Mara Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kuala Lumpur : University Malaya Medical Centre Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kuala Lumpur : Universiti Kebangsaan Malaysia Medical Centre Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kuantan : Hospital Tengku Ampuan Afzan Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Penang : Hospital Pulau Pinang Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Taiping : Taiping Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mexico
Distrito Federal : Instituto Nacional de Pediatría Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Distrito Federal : Médica Sur, S.A.B. de C.V. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Distrito Federal : Instituto Nacional de Pediatría Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Distrito Federal : Médica Sur, S.A.B. de C.V. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Guadalajara : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
View More »
Guadalajara : 205.444.52002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Guadalajara, JAL : Instituto Jalisciense de Investigacion Clinica Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Guadalajara, JAL : Instituto Jalisciense de Investigacion Clinica Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Hermosillo : 205.444.52001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Hermosillo Sonora : 205.456.52001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mexico City : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Mexico City, Distrito Federal : Hospital Angeles Lindavista Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Mexico City, Distrito Federal : Hospital Angeles Lindavista Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Monterrey : Hospital Universitario - Dr. José Eleuterio Gonzalez Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Monterrey : 205.456.52002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Morelia : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Nuevo León : 205.456.52004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Sonora : Hospital General del Estado de Sonora Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Sonora : Hospital General del Estado de Sonora Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tijuana, B.C. : Operadora de Hospitales Angeles, S.A de C.V. (Hospital Angel Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tijuana, B.C. : Operadora de Hospitales Angeles, S.A de C.V. (Hospital Angel Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Villahermosa : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Zapopan : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Zapopan : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Netherlands
Almelo : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Amsterdam : Academic Medical Center
Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
Eindhoven : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Groningen : University Medical Center Groningen
Development of Small Airway Disease Questionnaire
Heerlen : Atrium MC Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Hoogwoud : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Zutphen : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
New Zealand
Dunedin : RMC Medical Research Ltd Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Hamilton : Waikato Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Otahuhu : Middlemore Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rotorua : Hinemoa House Family Healthcare Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tauranga : Bay of Plenty Medical Research Trust Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Wellington : Medical Research Institute of New Zealand Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Pakistan
Vehari : District Headquarters Hospital
Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health (ESS-EMCH) Training by Assessing the Doctors' Practices
Peru
Cercado de Lima, Lima : Clinica Internacional Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Complejo Hospitalario San Pablo Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Alfredo Berrocal Kasay Reuma Sociedad de Responsabilidad Lim Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Centro de Investigación Ricardo Palma Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Hospital Cayetano Heredia Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Lima : Hospital Nacional Luis N. de la Policia Nacional del Peru Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Hospital Nacional Edgardo Rebagliati Martins Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Clinica San Borja Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Lima : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Lima : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Lima 18 : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Lima 27 : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Borja : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
San Miguel : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Miguel : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Philippines
Governor Mangubat Drive, Dasma : De La Salle University Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Manila : Philippine General Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : Quirino Memorial Medical Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : Lung Center of the Philippines Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : FEU-NRMF Medical Center, Bioethics Review Committee Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Quezon City : Philippine Heart Center Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Quezon City : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Poland
Bialystok : Prywatny Gabinet Internistyczno-Alergologiczny Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bialystok : Prywatny Gabinet Internistyczno-Alergologiczny Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Białystok : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bydgoszcz : 10 Wojskowy Szpital Kliniczny z Poliklinika Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bydgoszcz : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
View More »
Bystra : Specjalistyczny Zespol Chorob Pluc i Gruzlicy w Bystrej Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Czestochowa : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Debica : Poradnia Alergologiczna
Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
Gdansk : Szpital Specjalistyczny Sw. Wojciecha Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Krakow : Prywatna Praktyka Lekarska
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Krakow : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Lodz : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Łódź : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Łódź : Uniwersytetu Medycznego
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Lublin : Niepubliczny Zaklad Opieki Zdrowotnej Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lublin : Niepubliczny Zaklad Opieki Zdrowotnej Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lublin : Dzieciecy Szpital Kliniczny im. Prof. Antoniego Gebali, Poli Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lublin : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Ostrow Wielkopolski : Poradnia Gruzlicy i Chorob Pluc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Ostrow Wielkopolski : Poradnia Gruzlicy i Chorob Pluc Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Pabianice : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Poznan : Centrum Alergologii Teresa Hofman
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Poznan : SNZOZ Alergologia Plus Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Poznan : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Sopot : Centrum Medyczne KARDIOTEL Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Sopot : Centrum Medyczne KARDIOTEL Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Strzelce Opolskie : Centrum Medyczne Lucyna Andrzej Dymek NZOZ S.C. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tarnow : Alergo-Med Specjalistyczna Przychodnia Lekarska Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tarnow : Alergo-Med Specjalistyczna Przychodnia Lekarska Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Wroclaw : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Qatar
Doha : Hamad Medical Corporation
Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)
Doha : Hamad Medical Corporation- Pediatriv Emergency Center
Correction of Vitamin D in Asthma Control
Romania
Bucharest : "Prof. Dr. Marius Nasta" National Institute of Pneumology Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bucharest : Novo Medica Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bucuresti : Updated
A Non-drug Study Profiling Asthma
Bucuresti : Spitalul Clinic Universitar de Urgenta Elias
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Cluj-Napoca : "Leon Daniello" Pneumophtysiology Clinical Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Iasi : Clinical Hospital of Pulmonary Disease Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Targu Mures : Targu Mures Emergency County Clinical Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Russian Federation
Barnaul : City Hospital #5 Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kazan : Kazan State Medical University Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kemerovo : Research Institute of Complex Cardiovascular Pathology Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kemerovo : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Klin : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
View More »
Moscow : 205.425.07003 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Moscow : 205.425.07004 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Moscow : Principal Military Clinical Hospital n.a. N.N.Burdenko Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Moscow : Research Pulmonology Institute of Roszdrav Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Moscow : City Clinical Hospital #7 Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Moscow : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Moscow : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Moscow : 205.444.70003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Moscow : Moscow State Medical University
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Nizhniy Novgorod : Nizhniy Novgorod State Medical Academy of Roszdrav Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Novosibirsk : Novosibirsk State Medical University Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Novosibirsk : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
St. Petersburg : 205.425.07001 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
St. Petersburg : 205.425.07002 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
St. Petersburg : St. Petersburg State Medical University n.a. I.P. Pavlov Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Petersburg : St. Petersburg State Medical University n.a. I.P. Pavlov Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Petersburg : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
St. Petersburg : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
St. Petersburg : 205.444.70004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
St. Petersburg : 205.444.70005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
St. Petersburg : 205.444.70002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
St.Petersburg : City Hospital # 26 Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tomsk : Tomsk Regional Clinical Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Voronezh : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Yaroslavl : Clinical Emergency Hospital n.a.N.V. Soloviev Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Yaroslavl : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Yaroslavl : 205.444.70001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Slovakia
Bardejov : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bojnice : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bradejov : NsP Sv. Jakuba, n.o., Bardejov Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bratislava : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Bratislava : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Dolný Smokovec : NZZ- Detská pneumologická a ftizeologická ambulanci
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Kosice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Levice : ZAPA JJ s.r.o. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Levice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Liptovsky Hradok : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Michalovce : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Nitra : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Spisska Nova Ves : Plucna ambulancia Hrebenar, s.r.o. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Surany : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Topolcany : ANA JJ s.r.o. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Trencin : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Vrable : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
South Africa
Cape Town : Elvis Irusen's Private Practice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cape Town : University of Cape Town Lung Institute Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cape Town : Dr. Jan H. Vermeulen Private Practice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cape Town : 205.456.27001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Centurion : I Engelbrecht Research (Pty) Limited Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Claremont : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Durban : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Durban : Vawda Z Private Practice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Durban : Westville Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Durban : 205.456.27002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Johannesburg : Newtown Clinical Research Centre Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Johannesburg : Soweto General Practice Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Krugersdorp : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Panorama : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Pietermariztburg : Research Site Updated
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Pretoria : Jacaranda Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Pretoria : Global Clinical Trials (Pty) Ltd Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Spain
Barcelona : Hospital de Sabadell
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Esplugues del Llobregat : 205.444.34007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Guadalajara : Hospital Universitario de Guadalajara
Impact of Adherence to Treatment in Asthma Control
Madrid : 205.444.34001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Majadahonda (Madrid) : 205.444.34004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
View More »
Marbella : 205.444.34005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Sabdadell : 205.444.34006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Salt : Teva Investigational Site 34103 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Valencia : 205.444.34008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Sweden
Göteborg : me3plus AB Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Göteborg : me3plus AB Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Göteborg : Göteborgs Universitet Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Linköping : Universitetssjukhuset i Linköping Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Luleå : Hermelinen Forskning Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Lund : Skånes Universitetssjukhus- Lund Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lund : Skånes Universitetssjukhus- Lund Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Malmö : Center för Läkemedelsstudier Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Malmö : Center för Läkemedelsstudier Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Taiwan
Taipei : Chang Cung Memorial Hospital
A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients
Taipei : National Taiwan University Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Taipei : Far Eastern Memorial Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Taipei : Tri-Service General Hospital
Safety Study of Anti-Asthma Agent BMEC-1217B
Taoyuan : Chang Gung Medical Foundation-Linkou Branch Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Thailand
Bangkok : Chest Disease Institute Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bangkok : Bumrungrad Hospital Public Company, Ltd. Clinical Research C Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bangkok : King Chulalongkorn Memorial Hospital, Chulalongkorn Universi Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Muang : Khon Kaen University Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nakhon Ratchasima : Maharat Nakhonratchasima Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ukraine
Dnipropetrovsk : Dnipropetrovsk State Medical Academy Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Donetsk : 205.425.38002 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Donetsk : Donetsk National Medical University n.a. M. Horkyy Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Donetsk : 205.444.38002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Ivano-Frankivsk : Ivano-Frankivsk National Medical University Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Kharkiv : Municipal Institution of Health Care City Clinical Hospital Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kharkiv : 205.444.38005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Kiev : 205.425.38004 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Kiev : 205.456.38003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Kiev : 205.444.38004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Kiev : 205.444.38003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Kyiv : DU "National Institute of Phthisiology and Pulmonology n.a. Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kyiv : Institute of Pediatrics
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Lviv : 205.456.38001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Lviv : 205.444.38001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Ternopil : Municipal Institution of Ternopil Regional Council "Ternopil Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Vinnytsya : Vinnytsya National Medical University n.a. M.I. Pyrohov Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Zaporizhya : 205.425.38003 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Zaporizhzhia : Municipal Institution "Zaporizhzhia Regional Clinical Hospit Updated
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Zaporizhzhia : Zaporizhzhia State Medical University
Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
Zaporizhzhya : 205.456.38002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
United Kingdom
Cawston : Optimum Patient Care
Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management
Leicester : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Leicester : Novartis Investigative Site
Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma
London : GSK Investigational Site
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
Manchester : Updated
A Non-drug Study Profiling Asthma
View More »
Manchester : Novartis Investigative Site
A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device
Manchester : Novartis Investigative Site
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
Wythenshawe : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Vietnam
Ho Chi Minh City : MSD Vietnam
Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)
